サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1387352

パニック障害市場レポート：2030年までの動向、予測、競合分析

Panic Disorders Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

パニック障害市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年11月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

パニック障害の動向と予測

世界のパニック障害市場は、2024年から2030年にかけてCAGR 7.8％で成長すると予測されます。この市場の主な促進要因は、パニック障害に罹患する患者数の増加、メンタルヘルスに対する認識と取り組みの高まりです。世界のパニック障害市場の将来は、病院、メンタルヘルスケアセンター、精神病院市場でのビジネスチャンスにより有望視されています。

パニック障害市場の洞察

Lucintelは、パニック発作の頻度と重症度の軽減に役立つことから、錠剤が引き続き大きなセグメントを占めると予測しています。

この市場の中で、メンタルヘルスケアセンターは、個人療法やグループ療法、投薬管理、危機介入など幅広いサービスを提供するため、最大セグメントであり続けると思われます。

北米は、メンタルヘルスに対する意識の高まりと高度に発達したヘルスケアインフラの存在により、予測期間中も最大セグメントであり続けると思われます。

本レポートでは、以下の11の主要な質問に回答している：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界のパニック障害市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界のパニック障害市場動向（2018-2023）と予測（2024-2030）
  • 用量別の世界のパニック障害市場
    • 錠剤
    • 注射
    • その他
  • タイプ別の世界のパニック障害市場
    • 広場恐怖症
    • 社会不安障害
    • 強迫性障害
    • 双極性障害
    • 心的外傷後ストレス障害（PTSD）
    • 特定の恐怖症
    • 全般性不安障害
    • 大鬱病性障害
  • 最終用途別の世界のパニック障害市場
    • 病院
    • メンタルヘルスケアセンター
    • 精神病院
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界のパニック障害市場
  • 北米のパニック障害市場
  • 欧州のパニック障害市場
  • アジア太平洋のパニック障害市場
  • その他地域のパニック障害市場

第5章 競合分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 用量別の世界のパニック障害市場の成長機会
    • タイプ別の世界のパニック障害市場の成長機会
    • 最終用途別の世界のパニック障害市場の成長機会
    • 地域別の世界のパニック障害市場の成長機会
  • 世界のパニック障害市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界のパニック障害市場の能力拡大
    • 世界のパニック障害市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Teva Pharmaceutical Industries
  • Sun Pharmaceutical Industries
  • Mylan
  • AstraZeneca
  • Abbott
  • Baxter
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche
  • GlaxoSmithKline
目次

Panic Disorders Trends and Forecast

The future of the global panic disorders market looks promising with opportunities in the hospitals, mental healthcare centres, and asylums markets. The global panic disorders market is expected to grow with a CAGR of 7.8% from 2024 to 2030. The major drivers for this market are increasing number of patients suffering from panic disorders and rising awareness and initiatives for mental health.

A more than 150-page report is developed to help in your business decisions.

Panic Disorders by Segment

The study includes a forecast for the global panic disorders by dosage, type, end use, and region.

Panic Disorders Market by Dosage [Shipment Analysis by Value from 2018 to 2030]:

  • Tablets
  • Injections
  • Others

Panic Disorders Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Agoraphobia
  • Social Anxiety Disorder
  • Obsessive-Compulsive Disorder
  • Bipolar Disorder
  • Post-Traumatic Stress Disorder
  • Specific Phobias
  • Generalized Anxiety Disorder
  • Major Depressive Disorder

Panic Disorders Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Mental Healthcare Centres
  • Asylums
  • Others

Panic Disorders Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Panic Disorders Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies panic disorders companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the panic disorders companies profiled in this report include-

  • Teva Pharmaceutical Industries
  • Sun Pharmaceutical Industries
  • Mylan
  • Astrazeneca
  • Abbott
  • Baxter
  • Bristol-Myers Squibb Company
  • Eli Lilly And Company
  • F. Hoffmann-La Roche
  • Glaxosmithkline

Panic Disorders Market Insights

Lucintel forecasts that tablets will remain the larger segment as it helps in reducing the frequency and severity of panic attacks.

Within this market, mental healthcare center will remain the largest segment as it delivers wide range of services, such as individual and group therapy, medication management, and crisis intervention.

North America will remain the largest segment over the forecast period due to rising awareness towards mental health and presence of highly developed healthcare infrastructure in the region.

Features of the Global Panic Disorders Market

Market Size Estimates: Panic disorders market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Panic disorders market size by dosage, type, end use, and region in terms of value ($B).

Regional Analysis: Panic disorders market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different dosage, types, end uses, and regions for the panic disorders market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the panic disorders market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for panic disorders market?

Answer: The global panic disorders market is expected to grow with a CAGR of 7.8% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the panic disorders market?

Answer: The major drivers for this market are increasing number of patients suffering from panic disorders and rising awareness and initiatives for mental health.

Q3. What are the major segments for panic disorders market?

Answer: The future of the panic disorders market looks promising with opportunities in the hospitals, mental healthcare centres, and asylums markets.

Q4. Who are the key panic disorders market companies?

Answer: Some of the key panic disorders companies are as follows:

  • Teva Pharmaceutical Industries
  • Sun Pharmaceutical Industries
  • Mylan
  • Astrazeneca
  • Abbott
  • Baxter
  • Bristol-Myers Squibb Company
  • Eli Lilly And Company
  • F. Hoffmann-La Roche
  • Glaxosmithkline

Q5. Which panic disorders market segment will be the largest in future?

Answer: Lucintel forecasts that tablets will remain the larger segment as it helps in reducing the frequency and severity of panic attacks.

Q6. In panic disorders market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest segment over the forecast period due to rising awareness towards mental health and presence of highly developed healthcare infrastructure in the region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the panic disorders market by dosage (tablets, injections, and others), type (agoraphobia, social anxiety disorder, obsessive-compulsive disorder, bipolar disorder, post-traumatic stress disorder, specific phobias, generalized anxiety disorder, and major depressive disorder), end use (hospitals, mental healthcare centres, asylums, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Panic Disorders Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Panic Disorders Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Panic Disorders Market by Dosage
    • 3.3.1: Tablets
    • 3.3.2: Injections
    • 3.3.3: Others
  • 3.4: Global Panic Disorders Market by Type
    • 3.4.1: Agoraphobia
    • 3.4.2: Social Anxiety Disorder
    • 3.4.3: Obsessive-Compulsive Disorder
    • 3.4.4: Bipolar Disorder
    • 3.4.5: Post-Traumatic Stress Disorder
    • 3.4.6: Specific Phobias
    • 3.4.7: Generalized Anxiety Disorder
    • 3.4.8: Major Depressive Disorder
  • 3.5: Global Panic Disorders Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Mental Healthcare Centres
    • 3.5.3: Asylums
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Panic Disorders Market by Region
  • 4.2: North American Panic Disorders Market
    • 4.2.2: North American Panic Disorders Market by End Use: Hospitals, Mental Healthcare Centres, Asylums, and Others
  • 4.3: European Panic Disorders Market
    • 4.3.1: European Panic Disorders Market by Dosage: Tablets, Injections, and Others
    • 4.3.2: European Panic Disorders Market by End Use: Hospitals, Mental Healthcare Centres, Asylums, and Others
  • 4.4: APAC Panic Disorders Market
    • 4.4.1: APAC Panic Disorders Market by Dosage: Tablets, Injections, and Others
    • 4.4.2: APAC Panic Disorders Market by End Use: Hospitals, Mental Healthcare Centres, Asylums, and Others
  • 4.5: ROW Panic Disorders Market
    • 4.5.1: ROW Panic Disorders Market by Dosage: Tablets, Injections, and Others
    • 4.5.2: ROW Panic Disorders Market by End Use: Hospitals, Mental Healthcare Centres, Asylums, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Panic Disorders Market by Dosage
    • 6.1.2: Growth Opportunities for the Global Panic Disorders Market by Type
    • 6.1.3: Growth Opportunities for the Global Panic Disorders Market by End Use
    • 6.1.4: Growth Opportunities for the Global Panic Disorders Market by Region
  • 6.2: Emerging Trends in the Global Panic Disorders Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Panic Disorders Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Panic Disorders Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Teva Pharmaceutical Industries
  • 7.2: Sun Pharmaceutical Industries
  • 7.3: Mylan
  • 7.4: AstraZeneca
  • 7.5: Abbott
  • 7.6: Baxter
  • 7.7: Bristol-Myers Squibb Company
  • 7.8: Eli Lilly and Company
  • 7.9: F. Hoffmann-La Roche
  • 7.10: GlaxoSmithKline